| 000 | 01680 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517211723.0 | ||
| 264 | 0 | _c20181109 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1532-4206 | ||
| 024 | 7 |
_a10.1080/07435800.2018.1454461 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMok, J | |
| 245 | 0 | 0 |
_aSkeletal response to treatment with teriparatide (TPD) after bisphosphonate in post-menopausal women with osteoporosis and a high prevalence of secondary risk factors in real-life setting of a metabolic bone clinic; effect of age and vitamin D status. _h[electronic resource] |
| 260 |
_bEndocrine research _cAug 2018 |
||
| 300 |
_a195-202 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAbsorptiometry, Photon |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFemur Neck _xdiagnostic imaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLumbar Vertebrae _xdiagnostic imaging |
| 650 | 0 | 4 |
_aOsteoporosis _xblood |
| 650 | 0 | 4 |
_aOsteoporotic Fractures _xblood |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTeriparatide _xadministration & dosage |
| 650 | 0 | 4 |
_aVitamin D _xanalogs & derivatives |
| 700 | 1 | _aBrown, C | |
| 700 | 1 | _aMoore, A E B | |
| 700 | 1 | _aMin, S S | |
| 700 | 1 | _aHampson, G | |
| 773 | 0 |
_tEndocrine research _gvol. 43 _gno. 3 _gp. 195-202 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/07435800.2018.1454461 _zAvailable from publisher's website |
| 999 |
_c28284577 _d28284577 |
||